Observational studyArthritis research & therapy2023

High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study.

Chen Rongyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.